Sai Life Sciences Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|
| Revenue | 576.83 | 438.05 | 391.92 |
| Operating Expense | 413.11 | 317.41 | 281.21 |
| Net Profit | 89.94 | 51.06 | 43.85 |
| Net Profit Margin | 15.59 | 11.66 | 11.19 |
| Earning Per Share | 4.32 | 2.74 | 2.32 |
| EBIDTA | 150.73 | 113.69 | 104.68 |
| Effective Tax Rate | 10.71 | 8.21 | 7.77 |
| Particulars | Mar 2025 |
|---|---|
| Revenue | 576.83 |
| Operating Expense | 413.11 |
| Net Profit | 89.94 |
| Net Profit Margin | 15.59 |
| Earning Per Share | 4.32 |
| EBIDTA | 150.73 |
| Effective Tax Rate | 10.71 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 1,418.68 | 1,157.40 | 841.02 |
| Operating Expenses Annual | 1,132.07 | 994.26 | 719.63 |
| Operating Profit Annual | 315.94 | 191.10 | 149.54 |
| Interest Annual | 79.72 | 70.64 | 47.49 |
| Depreciation | 98.80 | 83.49 | 76.77 |
| Net Profit Annual | 95.23 | 24.24 | 15.68 |
| Tax Annual | 33.77 | 8.45 | 6.67 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 1,418.68 |
| Operating Expenses Annual | 1,132.07 |
| Operating Profit Annual | 315.94 |
| Interest Annual | 79.72 |
| Depreciation | 98.80 |
| Net Profit Annual | 95.23 |
| Tax Annual | 33.77 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 29.21 | 109.01 | 34.31 |
| Cash Flow from Operations | 250.64 | 221.47 | 88.38 |
| Cash Flow from Investing | -190.05 | -111.23 | -94.63 |
| Cash Flow from Financing | -84.63 | -190.04 | 80.95 |
| Cash Flow at the End | 5.17 | 29.21 | 109.01 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 29.21 |
| Cash Flow from Operations | 250.64 |
| Cash Flow from Investing | -190.05 |
| Cash Flow from Financing | -84.63 |
| Cash Flow at the End | 5.17 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 22.37 | 16.83 | 16.85 |
| PBIT Margin (%) | 14.81 | 9.25 | 7.37 |
| PBT Margin (%) | 14.63 | 9.13 | 7.22 |
| Net PROFIT Margin (%) | 6.71 | 2.09 | 1.86 |
| Return On Networth / Equity (%) | 9.90 | 2.69 | 0.50 |
| Return On Networth /Employed (%) | 11.36 | 5.96 | 3.72 |
| Return On Assets (%) | 5.17 | 1.34 | 0.93 |
| Total Debt / Equity (X) | 0.90 | 0.90 | 0.79 |
| Asset Turnover Ratio (%) | 0.77 | 0.64 | 0.50 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 22.37 |
| PBIT Margin (%) | 14.81 |
| PBT Margin (%) | 14.63 |
| Net PROFIT Margin (%) | 6.71 |
| Return On Networth / Equity (%) | 9.90 |
| Return On Networth /Employed (%) | 11.36 |
| Return On Assets (%) | 5.17 |
| Total Debt / Equity (X) | 0.90 |
| Asset Turnover Ratio (%) | 0.77 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 1,073.75 | 922.59 | 857.59 |
| Total Current Assets Annual | 951.17 | 951.93 | 943.66 |
| Non Current Assets Annual | 1,288.75 | 1,178.69 | 1,162.23 |
| Total Shareholders Funds Annual | 1,011.20 | 912.73 | 891.04 |
| Total Assets Annual | 2,239.92 | 2,130.62 | 2,105.89 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 1,073.75 |
| Total Current Assets Annual | 951.17 |
| Non Current Assets Annual | 1,288.75 |
| Total Shareholders Funds Annual | 1,011.20 |
| Total Assets Annual | 2,239.92 |
EPS (INR)
Expected
4.24
Reported
4.24
Surprise
0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 11.58%
Jun 2024
EPS beaten by -89.90%
